Business Wire

NY-CONDECO

12.4.2022 14:32:15 CEST | Business Wire | Press release

Share
Employees Want the Best of Both Worlds: New Survey From Condeco Reveals Critical Facets of Hybrid Work That Business Leaders Need to Address

Condeco , a global leader in workspace scheduling software, is today announcing new research that reveals the importance of fostering a workplace that understands and respects employee needs, with hybrid work opportunities at its core. Its findings support the understanding that hybrid capabilities lead to greater employee advocacy and happiness at work and show that when it comes to recommending their company, hybrid workers can be the biggest advocates.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220412005267/en/

Allowing for a better work-life balance was identified as one of the biggest benefits of hybrid working through Condeco’s new research, which shows a direct relationship between employee satisfaction and improved mental and emotional well-being. Significantly, more than a third of workers surveyed reported that a hybrid work model has positively impacted their mental and physical health.

“Everyone wants something different out of work, but we can clearly see that almost no one wants to be back in the office full-time,” said Paul Statham, Condeco’s CEO & Founder. “We all know by now that hybrid models are key to ensuring a healthy work-life balance, but how each employer acts on that realization will determine their employees’ fulfillment with their company. No one is suggesting that the office is obsolete, on the contrary, it remains a vital place for employees to collaborate and engage. Business leaders looking to provide the best of both worlds for their employees must find a way to transform their offices from a place employees have to go to a place they want to go.”

“The need to have the right digital tools in place has emerged as one of the most important things to get right for hybrid working,” continued Lynda Lowe, CMO at Condeco. “But different generations have different definitions of what the ‘right tools’ are. This research clearly shows the biggest barriers to hybrid working and the fact that many employees still don’t feel that their company is using the right tools for hybrid working.”

Condeco polled 1,500 of today’s workers to get a pulse on the attitudes towards hybrid work and how these feelings are impacting businesses’ acclimation to the future of the working world. Key findings include:

Hybrid Workers Are Happy Workers – And in Turn, They’re Your Most Loyal Employees

  • 62% of respondents said they feel satisfied with their current hybrid work schedule – and fostering a work culture that brings happiness helps employers attract and retain top talent.
  • Hybrid workers are employers’ biggest advocates, with 63% saying they would recommend their company as an ideal work destination.
  • Nearly half of those back in their offices full-time would like to be more hybrid, which employers struggling with the ‘Great Resignation’ appear not to be considering.

Hybrid Work Has Had a Positive Impact on Mental Health, But There Is Still Room for Improvement

  • 34% of respondents feel that hybrid working has had a positive impact on their mental and physical health, with only 11% feeling that it has had a negative effect.
  • 69% of hybrid workers agreed that their employer takes into consideration the emotional and mental wellbeing of employees.
  • The number one benefit of hybrid working was a better work-life balance, with the lack of a social environment offered by work being the biggest barrier to remote working.

Tech Is the Backbone of Hybrid Work – Yet Only Half of Today’s Employees Have the Right Tools

  • Businesses have realized the opportunity of hybrid working – 78% of managers believe their business has been streamlined as a result and 80% trust their employees to get their work done.
  • Having the right digital tools was identified as the top need to ensuring hybrid working, but only 51% of employees agree that their company is using the right tools to support flexible work and only 50% of respondents feel their company is open to feedback about their digital tool stack.
  • Companies are grappling with how best to bring employees back to the office on a flexible basis. To ensure collaboration and high productivity, employers must consider their workplace tech as the backbone to their strategy.

As part of Condeco’s broader marketing campaign that addresses today’s cultural shift in business, Condeco is today releasing a new film short that shines light on the generational divide that has emerged out of the pandemic, and light-heartedly cements the importance of having an employer that understands and embraces employee needs. You can see the full broadcast here .

To download Condeco’s full survey, complete with additional statistics and methodology, please visit: https://www.condecosoftware.com/modern-workplace/research/attitudes-to-hybrid-working-report-2022/ .

About Condeco

Condeco is the global leader in enterprise level workspace solutions. Our software is designed to equip everyone with the tools they need for a seamless end to end experience in today’s office. By giving people control over flexible work, we deliver the certainty people need, enable the collaboration teams crave, and facilitate the insights on capacity that employers demand. From visitor management to workspace booking to office optimization, we are trusted by over 2000 of the world’s largest companies to realize their future at work.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye